Akums Drugs and Pharmaceuticals, a leading contract manufacturing pharmaceutical company, recently completed the acquisition of a state-of-the-art drug formulation facility located in Baddi, Himachal Pradesh.
This new facility marks a significant expansion for Akums and is poised to bolster its tablet manufacturing business. Anticipated to commence operations in the upcoming year, this facility represents the company's 12th formulation unit and its second in Baddi. The strategic expansion aligns seamlessly with Akums' commitment to enhancing manufacturing capabilities across diverse geographical regions, underscoring its dedication to the well-being of local communities.
Furthermore, Akums is actively pursuing backward integration through the establishment of API plants, reinforcing its focus on comprehensive pharmaceutical solutions.
Against the backdrop of a dynamic pharmaceutical landscape, the Indian market experienced noteworthy growth in FY23, with a year-on-year increase of nearly five percent, reaching an impressive USD 49.78 billion. This robust growth reflects the company's resilience and strategic positioning within the thriving pharmaceutical sector.
News by Rahul Yelligetti